203 related articles for article (PubMed ID: 17595789)
21. Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis.
Seo HY; Kim DS; Choi YS; Sung HJ; Park KH; Choi IK; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
Cancer Chemother Pharmacol; 2009 Feb; 63(3):433-9. PubMed ID: 18398608
[TBL] [Abstract][Full Text] [Related]
22. [Leucovorin and 5-FU for advanced gastrointestinal cancer].
Sasaki T; Maeda Y; Kobayashi T
Gan To Kagaku Ryoho; 1999 Mar; 26(4):440-6. PubMed ID: 10097740
[TBL] [Abstract][Full Text] [Related]
23. A retrospective study of bifractionated CPT-11 with LF5FU infusion (FOLFIRI-3) in colorectal cancer patients pretreated with oxaliplatin and CPT-11 containing chemotherapies.
Viel E; Demarchi MF; Chaigneau L; Nguyen T; Legat C; Stein U; Thiery-Vuillemin A; Limat S; Pivot X; Borg C
Am J Clin Oncol; 2008 Feb; 31(1):89-94. PubMed ID: 18376234
[TBL] [Abstract][Full Text] [Related]
24. Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer.
Kabbinavar FF; Hambleton J; Mass RD; Hurwitz HI; Bergsland E; Sarkar S
J Clin Oncol; 2005 Jun; 23(16):3706-12. PubMed ID: 15867200
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
Yamasaki T; Kimura T; Kurokawa F; Aoyama K; Ishikawa T; Tajima K; Yokoyama Y; Takami T; Omori K; Kawaguchi K; Tsuchiya M; Terai S; Sakaida I; Okita K
J Gastroenterol; 2005 Jan; 40(1):70-8. PubMed ID: 15692792
[TBL] [Abstract][Full Text] [Related]
26. Low-dose leucovorin and 5-Fluorouracil for unresectable multiple liver metastasis from colorectal cancer.
Ishibashi K; Yoshimatsu K; Yokomizo H; Umehara A; Yoshida K; Fujimoto T; Watanabe K; Katsube T; Naritaka Y; Ogawa K
Anticancer Res; 2005; 25(6C):4747-52. PubMed ID: 16334171
[TBL] [Abstract][Full Text] [Related]
27. Weekly infusional high-dose 5-fluorouracil and leucovorin and biweekly cisplatin: a convenient treatment option in advanced gastric cancer.
Kundel Y; Purim O; Figer A; Stemmer SM; Tichler T; Sulkes J; Sulkes A; Brenner B
Med Sci Monit; 2008 Apr; 14(4):CR190-5. PubMed ID: 18376346
[TBL] [Abstract][Full Text] [Related]
28. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.
Boige V; Malka D; Elias D; Castaing M; De Baere T; Goere D; Dromain C; Pocard M; Ducreux M
Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145
[TBL] [Abstract][Full Text] [Related]
29. [Retrospective analysis on efficacy and toxicity of 5-fluorouracil (5-FU) and l-leucovorin (l-LV) in advanced or recurrent colorectal cancer].
Chiba N; Yoshioka T; Kato S; Takahashi S; Shibata H; Kato S; Sakayori M; Otsuka K; Kakudo Y; Ohori H; Yamaura G; Takahashi M; Yasuda K; Ishioka C
Gan To Kagaku Ryoho; 2005 Jul; 32(7):991-5. PubMed ID: 16044961
[TBL] [Abstract][Full Text] [Related]
30. Retrospective study as first-line chemotherapy combined anti-VEGF antibody with fluoropyrimidine for frail patients with unresectable or metastatic colorectal cancer.
Yoshida M; Goto M; Kii T; Nishitani H; Kawabe S; Kuwakado S; Asaishi K; Miyamoto T; Higuchi K
Digestion; 2013; 87(1):59-64. PubMed ID: 23343971
[TBL] [Abstract][Full Text] [Related]
31. [The evaluation of LFH or LFPH in the treatment of advanced cancer of gastric cardia and colorectal cancer].
Zhang XD; Shen L; Li Y; Li J; Yang BQ; Jin ML
Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):289-91. PubMed ID: 12839698
[TBL] [Abstract][Full Text] [Related]
32. Clinical trial of low-dose leucovorin plus 5-fluorouracil for patients with metastatic colorectal cancer.
Yamaguchi Y; Sawamura A; Minami K
Hepatogastroenterology; 2007; 54(77):1394-7. PubMed ID: 17708262
[TBL] [Abstract][Full Text] [Related]
33. [Effect of leucovorin and 5-FU for advanced colorectal cancer patients].
Tanemura H; Tanaka S; Oshita H
Gan To Kagaku Ryoho; 1996 Apr; 23(5):579-86. PubMed ID: 8678516
[TBL] [Abstract][Full Text] [Related]
34. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
[TBL] [Abstract][Full Text] [Related]
35. Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival.
Hotta T; Takifuji K; Arii K; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Oku Y; Yamaue H
Anticancer Res; 2006; 26(2B):1425-32. PubMed ID: 16619554
[TBL] [Abstract][Full Text] [Related]
36. [10-hydroxy-camptothecin plus fluorouracil/leucovorin for the treatment of patients with advanced colorectal cancer].
Zhang HG; Cai RG; Chen SS; Wu F; Chu DT
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1462-4. PubMed ID: 17785082
[TBL] [Abstract][Full Text] [Related]
37. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis.
Thirion P; Michiels S; Pignon JP; Buyse M; Braud AC; Carlson RW; O'Connell M; Sargent P; Piedbois P;
J Clin Oncol; 2004 Sep; 22(18):3766-75. PubMed ID: 15365073
[TBL] [Abstract][Full Text] [Related]
38. Mitomycin-C, 5-fluorouracil, and leucovorin as a salvage therapy in patients with metastatic colorectal adenocarcinoma.
Kang EJ; Choi YJ; Kim JS; Kim ST; Park KH; Choi IK; Oh SC; Seo JH; Shin SW; Kim JS; Kim YH
Asia Pac J Clin Oncol; 2010 Dec; 6(4):286-91. PubMed ID: 21114778
[TBL] [Abstract][Full Text] [Related]
39. Continuous infusion of 5-fluorouracil with versus without low-dose, consecutive administration of cisplatin in advanced colorectal cancer. A prospective randomized phase II study.
Nakata B; Sowa M; Tsuji A; Kamano T; Sasaki K; Fukunaga Y; Takahashi M; Tsujitani S; Mikami Y; Mitachi Y; Nishimura S; Araki H; Yamamitsu S; Hirakawa K; Tominaga S; Shirasaka T; Inokuchi K
J Exp Clin Cancer Res; 2007 Mar; 26(1):51-60. PubMed ID: 17550132
[TBL] [Abstract][Full Text] [Related]
40. [Efficacy of uracil/tegafur (UFT) plus oral Leucovorin (LV) therapy for colorectal cancer in elderly patients].
Mizushima T; Mizuno H; Ito T; Hoki M; Souma Y; Iwamoto T; Ozawa H; Kanou T; Nakamori Y; Iwase K
Gan To Kagaku Ryoho; 2006 Jul; 33(7):941-4. PubMed ID: 16835484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
